Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1231626.RArp46_eFRAxkRCgB7a8xm6fEg8Dtq_c2aJgPZLPDh1UY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1231626.RArp46_eFRAxkRCgB7a8xm6fEg8Dtq_c2aJgPZLPDh1UY130_assertion type Assertion NP1231626.RArp46_eFRAxkRCgB7a8xm6fEg8Dtq_c2aJgPZLPDh1UY130_head.
- NP1231626.RArp46_eFRAxkRCgB7a8xm6fEg8Dtq_c2aJgPZLPDh1UY130_assertion description "[Among invasive ductal carcinomas, 29% (115/390) showed chromosome 17 aneuploidy, mostly associated with grade 3/HER2 2+ (45%) or grade 2/HER2 3+ (55%) that were not amplified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231626.RArp46_eFRAxkRCgB7a8xm6fEg8Dtq_c2aJgPZLPDh1UY130_provenance.
- NP1231626.RArp46_eFRAxkRCgB7a8xm6fEg8Dtq_c2aJgPZLPDh1UY130_assertion evidence source_evidence_literature NP1231626.RArp46_eFRAxkRCgB7a8xm6fEg8Dtq_c2aJgPZLPDh1UY130_provenance.
- NP1231626.RArp46_eFRAxkRCgB7a8xm6fEg8Dtq_c2aJgPZLPDh1UY130_assertion SIO_000772 25337277 NP1231626.RArp46_eFRAxkRCgB7a8xm6fEg8Dtq_c2aJgPZLPDh1UY130_provenance.
- NP1231626.RArp46_eFRAxkRCgB7a8xm6fEg8Dtq_c2aJgPZLPDh1UY130_assertion wasDerivedFrom befree-2016 NP1231626.RArp46_eFRAxkRCgB7a8xm6fEg8Dtq_c2aJgPZLPDh1UY130_provenance.
- NP1231626.RArp46_eFRAxkRCgB7a8xm6fEg8Dtq_c2aJgPZLPDh1UY130_assertion wasGeneratedBy ECO_0000203 NP1231626.RArp46_eFRAxkRCgB7a8xm6fEg8Dtq_c2aJgPZLPDh1UY130_provenance.